Qiagen buys German Rosys for $16 million:
This article was originally published in Clinica
Qiagen has bought the German company, Rosys, which makes robotic handling systems and liquid-handling instrumentation, for approximately $16 million in a stock-for-stock transaction. Rosys was an OEM supplier for five years to Qiagen's BioRobot lines. Qiagen is based in Venlo, Netherlands.
You may also be interested in...
Mylan and Pfizer’s Upjohn, already facing a delay to their proposed merger, may have to overcome regulatory barriers to get the deal over the line.
National export restrictions on medicines have been slammed by the international off-patent pharmaceutical industry as being “counter-productive” during the coronavirus crisis. The IGBA is instead urging international co-operation and transparency, pointing to a positive example of supply-chain connectivity in the Asia-Pacific region.
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.